SPS
MRNA icon

Susquehanna Portfolio Strategies’s Moderna MRNA Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33M Hold
471,043
– – 0.53% 47
2026
Q1 		$23.9M Hold
471,043
– – 0.36% 77
2025
Q4 		$13.9M Buy
+471,043
New +$12.8M 0.21% 131
2025
Q3 		– Sell
-78,800
Closed -$2.17M – 1091
2025
Q2 		$2.17M Buy
+78,800
New +$2.08M 0.05% 356

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Susquehanna Portfolio Strategies's MRNA Position: Q2 2026 in Review

Susquehanna Portfolio Strategies held its Moderna (MRNA) position steady in Q2 2026 at 471,043 shares worth $33M. The position accounts for 0.53% of the portfolio, ranked #47.

Susquehanna Portfolio Strategies first reported a position in MRNA in Q2 2025 and has held it in 4 quarters since. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Susquehanna Portfolio Strategies held 471,043 shares of Moderna worth $33M as of Q2 2026.
  • Susquehanna Portfolio Strategies left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.53% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #47 holding.
  • Susquehanna Portfolio Strategies first reported a position in Moderna in Q2 2025 and has held it in 4 quarters since.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.